GSK Looks To Expand OTC Reach With CNS Brands
This article was originally published in The Tan Sheet
Executive Summary
GlaxoSmithKline will pay nearly five times CNS's 12-month sales total to widen its consumer reach with the acquisition of CNS, the Minneapolis-based maker of Breathe Right and FiberChoice products